Cargando…

Extracellular vesicles and Alzheimer’s disease in the novel era of Precision Medicine: implications for disease progression, diagnosis and treatment

Extracellular vesicles (EVs), secreted membranous nano-sized particles, are critical intercellular messengers participating in nervous system homeostasis, while recent evidence implicates EVs in Alzheimer’s disease (AD) pathogenesis. Specifically, small EVs have been shown to spread toxic proteins,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomes, Patrícia, Tzouanou, Foteini, Skolariki, Konstantina, Vamvaka-Iakovou, Anastasia, Noguera-Ortiz, Carlos, Tsirtsaki, Katerina, Waites, Clarissa L., Vlamos, Panagiotis, Sousa, Nuno, Costa-Silva, Bruno, Kapogiannis, Dimitrios, Sotiropoulos, Ioannis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985072/ https://www.ncbi.nlm.nih.gov/pubmed/35952764 http://dx.doi.org/10.1016/j.expneurol.2022.114183

Ejemplares similares

A novel isolation method for spontaneously released extracellular vesicles from brain tissue and its implications for stress-driven brain pathology
por: Gomes, Patrícia A., et al.
Publicado: (2023)

Revolutionizing the Early Detection of Alzheimer’s Disease through Non-Invasive Biomarkers: The Role of Artificial Intelligence and Deep Learning
por: Vrahatis, Aristidis G., et al.
Publicado: (2023)

Machine Learning Analysis of Alzheimer’s Disease Single-Cell RNA-Sequencing Data across Cortex and Hippocampus Regions
por: Krokidis, Marios G., et al.
Publicado: (2023)

Assessing and Modelling of Post-Traumatic Stress Disorder Using Molecular and Functional Biomarkers
por: Skolariki, Konstantina, et al.
Publicado: (2023)

Predictive models for mild cognitive impairment to Alzheimer’s disease conversion
por: Skolariki, Konstantina, et al.
Publicado: (2021)

Novel modeling methodologies for the neuropathological dimensions of Parkinson's disease
por: Vlamos, Panagiotis
Publicado: (2020)

Glucocorticoid stress hormones stimulate vesicle-free Tau secretion and spreading in the brain
por: Waites, Clarissa, et al.
Publicado: (2023)

The focal adhesion protein Integrin-Linked Kinase (ILK) as an important player in breast cancer pathogenesis
por: Tsirtsaki, Katerina, et al.
Publicado: (2020)

Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
por: Hampel, Harald, et al.
Publicado: (2019)

Can detection and prediction models for Alzheimer’s Disease be applied to Prodromal Parkinson’s Disease using explainable artificial intelligence? A brief report on Digital Neuro Signatures.
por: Tarnanas, Ioannis, et al.
Publicado: (2022)

Rab35 and glucocorticoids regulate APP and BACE1 trafficking to modulate Aβ production
por: Zhuravleva, Viktoriya, et al.
Publicado: (2021)

A Sensor-Based Perspective in Early-Stage Parkinson’s Disease: Current State and the Need for Machine Learning Processes
por: Krokidis, Marios G., et al.
Publicado: (2022)

Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine
por: Samuel, Younan, et al.
Publicado: (2023)

Nodular Thyroid Disease in the Era of Precision Medicine
por: Tumino, Dario, et al.
Publicado: (2020)

Coordination of synaptic vesicle trafficking and turnover by the Rab35 signaling network
por: Sheehan, Patricia, et al.
Publicado: (2017)

Alzheimer’s Disease-Related Genes Identified by Linking Spatial Patterns of Pathology and Gene Expression
por: Mullins, Roger, et al.
Publicado: (2022)

Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease
por: Yao, Pamela J., et al.
Publicado: (2021)

Gender Disparity in Cardiovascular Disease in the Era of Precision Medicine
por: Hosseini, Naeimeh, et al.
Publicado: (2023)

Parkinson’s disease-linked Parkin mutations impair glutamatergic signaling in hippocampal neurons
por: Zhu, Mei, et al.
Publicado: (2018)

Time distortions in Alzheimer’s disease: a systematic review and theoretical integration
por: El Haj, Mohamad, et al.
Publicado: (2016)

Precision Surgery of Colorectal Liver Metastases in the Current Era: A Systematic Review
por: Papaconstantinou, Dimitrios, et al.
Publicado: (2023)

Mathematical Multidimensional Modelling and Structural Artificial Intelligence Pipelines Provide Insights for the Designing of Highly Specific AntiSARS-CoV2 Agents
por: Vlachakis, Dimitrios, et al.
Publicado: (2021)

In Silico Structural Analysis Exploring Conformational Folding of Protein Variants in Alzheimer’s Disease
por: Efraimidis, Evangelos, et al.
Publicado: (2023)

Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era
por: Xu, Mengda, et al.
Publicado: (2021)

Repurposing drugs to treat cardiovascular disease in the era of precision medicine
por: Abdelsayed, Mena, et al.
Publicado: (2022)

False Memory in Alzheimer's Disease
por: El Haj, Mohamad, et al.
Publicado: (2020)

The era of precision oncogenomics
por: Carpten, John C., et al.
Publicado: (2018)

Radiosynoviorthesis after Surgery in the Treatment of Patients with Ankle Pigmented Villonodular Synovitis: A Case Series
por: Iakovou, Ioannis, et al.
Publicado: (2020)

Insulin Resistance Predicts Medial Temporal Hypermetabolism in Mild Cognitive Impairment Conversion to Alzheimer Disease
por: Willette, Auriel A., et al.
Publicado: (2015)

Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020)

Precision medicine in the era of artificial intelligence: implications in chronic disease management
por: Subramanian, Murugan, et al.
Publicado: (2020)

Corrigendum: Targeted therapy in cardiovascular disease: A precision therapy era
por: Xu, Mengda, et al.
Publicado: (2023)

Modeling the mitochondrial dysfunction in neurogenerative diseases due to high H+ concentration
por: Alexiou, Athanasios, et al.
Publicado: (2011)

Biobanking in the era of precision oncology
por: Saini, Kamal S., et al.
Publicado: (2015)

Biomarkers in the Era of Precision Oncology
por: Baxevanis, Constantin N.
Publicado: (2023)

Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine
por: Sepahzad, Afsoon, et al.
Publicado: (2021)

Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
por: Vlachakis, Dimitrios, et al.
Publicado: (2021)

Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era
por: Li, Dunhui, et al.
Publicado: (2020)

Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology
por: Liu, Xin-Yu, et al.
Publicado: (2023)

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
por: Mullins, Roger J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_so6jf4c4fm0vlvus86g1lgn60b